{"id":"full-spectrum-cannabidiol","safety":{"commonSideEffects":[{"rate":"10%","effect":"Dizziness"},{"rate":"8%","effect":"Somnolence"},{"rate":"5%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Cannabidiol is a non-psychoactive compound found in cannabis that has been shown to have anxiolytic and antipsychotic effects through its action as a CB1 receptor antagonist.","oneSentence":"Cannabidiol acts as a CB1 receptor antagonist","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:33:20.840Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Epilepsy"},{"name":"Anxiety"}]},"trialDetails":[{"nctId":"NCT07498023","phase":"PHASE1, PHASE2","title":"EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-09-15","conditions":"Fibromyalgia","enrollment":36},{"nctId":"NCT02548559","phase":"PHASE2","title":"Sublingual Cannabidiol for Anxiety","status":"COMPLETED","sponsor":"Staci Gruber, Ph.D.","startDate":"2018-08-14","conditions":"Anxiety","enrollment":46},{"nctId":"NCT05753007","phase":"PHASE2","title":"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2024-02-15","conditions":"Glioblastoma","enrollment":2},{"nctId":"NCT07279558","phase":"PHASE2","title":"Cannabidiol and Alcohol Use Disorder Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT07298408","phase":"PHASE1, PHASE2","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Florida A&M University","startDate":"2026-01-02","conditions":"Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies","enrollment":20},{"nctId":"NCT05644262","phase":"PHASE2","title":"Life's End Benefits of cannaBidiol and tetrahYdrocannabinol","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2023-12-18","conditions":"Agitation, Dementia","enrollment":120},{"nctId":"NCT05632627","phase":"PHASE2","title":"Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-04-11","conditions":"Brain Injuries, Traumatic","enrollment":43},{"nctId":"NCT05299944","phase":"PHASE2","title":"Reducing Pain and Opioid Use With CBD","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-03-08","conditions":"Opioid Use Disorder","enrollment":126},{"nctId":"NCT06414473","phase":"PHASE1, PHASE2","title":"CBD for Knee Osteoarthritis","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-06-14","conditions":"Osteoarthritis, Knee","enrollment":30},{"nctId":"NCT06266611","phase":"PHASE2","title":"Cannabis for Palliative Care in Cancer","status":"RECRUITING","sponsor":"University of Colorado, Boulder","startDate":"2024-09-16","conditions":"Sleep, Anxiety, Depression","enrollment":185},{"nctId":"NCT06107062","phase":"PHASE2","title":"Longitudinal Outpatient Treatment for Cannabis Use Disorder","status":"RECRUITING","sponsor":"University of Colorado, Boulder","startDate":"2024-05-16","conditions":"Cannabis Use Disorder","enrollment":165},{"nctId":"NCT04075435","phase":"EARLY_PHASE1","title":"Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2021-01-11","conditions":"Alzheimer Disease, Anxiety, Agitation,Psychomotor","enrollment":12},{"nctId":"NCT06477406","phase":"PHASE2","title":"Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-02-27","conditions":"Endometriosis","enrollment":30},{"nctId":"NCT05456113","phase":"NA","title":"Topical Cannabidiol Application and Skin Vascular Reactivity","status":"WITHDRAWN","sponsor":"Penn State University","startDate":"2024-12-01","conditions":"Effect of Drug","enrollment":""},{"nctId":"NCT04873453","phase":"PHASE2","title":"CBD for the Treatment of Alcohol Use Disorder","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-08-30","conditions":"Alcohol Use Disorder","enrollment":45},{"nctId":"NCT05822362","phase":"PHASE2","title":"CBD for Individuals at Risk for Alzheimer's Disease","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-01-19","conditions":"Mild Cognitive Impairment","enrollment":236},{"nctId":"NCT05613608","phase":"PHASE2, PHASE3","title":"Alcohol Use Disorder and Cannabidiol","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-04-30","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT04634136","phase":"NA","title":"Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-10-15","conditions":"Children, Adult, Spastic Cerebral Palsy, Quality of Life","enrollment":55},{"nctId":"NCT06290063","phase":"PHASE2","title":"Cannabidiol and Older Adult Cannabis Users","status":"RECRUITING","sponsor":"University of Colorado, Boulder","startDate":"2024-05-01","conditions":"Sleep, Anxiety, Depression","enrollment":385},{"nctId":"NCT04997395","phase":"PHASE2","title":"Feasibility of Cannabidiol for the Treatment of Long COVID","status":"COMPLETED","sponsor":"Bod Australia","startDate":"2022-04-14","conditions":"Long COVID","enrollment":12},{"nctId":"NCT05023759","phase":"","title":"Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)","status":"COMPLETED","sponsor":"Formula30A LLC","startDate":"2020-06-01","conditions":"Generalized Anxiety Disorder","enrollment":30},{"nctId":"NCT04267679","phase":"PHASE2","title":"Cannabidiol for Anxiety","status":"WITHDRAWN","sponsor":"CB2 Insights","startDate":"2020-03-01","conditions":"Anxiety","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":79,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Full-Spectrum Cannabidiol","genericName":"Full-Spectrum Cannabidiol","companyName":"Staci Gruber, Ph.D.","companyId":"staci-gruber-ph-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cannabidiol acts as a CB1 receptor antagonist Used for Epilepsy, Anxiety.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}